9/3/2008 11:50:31 AM
Abingworth, the international life sciences and healthcare investment group, announces the sale of Clinical Designs Limited to Mundipharma International Corporation Limited. Abingworth were majority shareholders in Clinical Designs, and its only financial backers. Financial terms of the acquisition have not been disclosed but this exit will have a significant impact on the Abingworth fund that made the investment.
comments powered by